ONCOS THERAPEUTICS
Oncos Therapeutics develops new cancer therapies based on its next generation oncolytic viruses. The company's unique Advanced Therapy Access Program was started in 2007 for cancer patients in whom standard-of-care therapies have failed. Today, 200 patients have undergone individually tailored oncolytic virus therapy suggesting strong safety and efficacy. The program is based on extensive scientific research at the University of Helsinki and serves as the foundation for ongoing clinical development.
ONCOS THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2007-01-01
Address:
Helsinki, Southern Finland, Finland
Country:
Finland
Website Url:
http://www.oncos.com
Total Employee:
11+
Status:
Active
Contact:
358 4005 69628
Email Addresses:
[email protected]
Total Funding:
5.5 M USD
Technology used in webpage:
Content Delivery Network Font Awesome Domain Not Resolving Microsoft Exchange Online IPv6 ReCAPTCHA Microsoft Azure DNS BootstrapCDN ASP.NET IIS
Similar Organizations
Affini-T Therapeutics
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Employees Featured
Founder
Investors List
HealthCap
HealthCap investment in Series C - Oncos Therapeutics
Official Site Inspections
http://www.oncos.com
- Host name: res3009pi.cloudpanel.it
- IP address: 185.201.65.96
- Location: Italy
- Latitude: 43.1479
- Longitude: 12.1097
- Timezone: Europe/Rome
More informations about "Oncos Therapeutics"
Oncos Therapeutics - Crunchbase Company Profile
Oncos Therapeutics is a biotech company developing cancer therapies based on its next generation oncolytic viruses.See details»
Oncos Therapeutics Management Team | Org Chart - RocketReach
Oncos Therapeutics employs 2 employees. The Oncos Therapeutics management team includes Ravinder Sudini (Co-Founder and Product Development Consultant), and Lotta Kangasniemi โฆSee details»
Oncos Therapeutics 2025 Company Profile: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for Oncos Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Oncos - Cosmetics cancer patients
Oncos is an Italian dermocosmetic brand specializing in the production of dermocosmetic products also suitable for cancer patients.See details»
Oncos Therapeutics Ltd. - Helsinki, Finland - bionity.com
Jan 24, 2011 Oncos Therapeutics develops novel cancer therapies based on its next generation oncolytic viruses. Since the onset of our Advanced Therapy Access Program in 2007, 200 โฆSee details»
Oncos Therapeutics - VentureRadar
"Oncos Therapeutics develops novel cancer therapies based on its next generation oncolytic viruses. Since the onset of our Advanced Therapy Access Program in 2007, 200 patients have โฆSee details»
ONCOS โ Website of the ONCOS Oncology Student โฆ
Our aim is to support students in discovering their path within this complex field, offering expert talks, social activities & networking, and research opportunities to help you explore your interests and potential career directions.See details»
Oncos Therapeutics - Products, Competitors, Financials, Employees ...
About Oncos Therapeutics Oncos is a privately funded clinical-stage biotechnology company focused on the development and commercialization of targeted cancer immunotherapy. โฆSee details»
Dermocosmetics for cancer patients - Oncos
Dermocosmetics for cancer patients: the Oncos line is designed to prevent and treat skin side effects from cancer therapies.See details»
Oncos - Wikipedia
Oncos is a registered trademark. Also their trademarks are Painea bฤtutฤ and Puiul de Floreศti. The holding component also includes: Oncos Tonus, Gym fitness & bodybuilding and Lany's โฆSee details»
Oncos - Products, Competitors, Financials, Employees, โฆ
About Oncos Oncos provides oncology services with a focus on radiotherapy and IT solutions within the healthcare sector. The company offers data backup and archiving solutions, โฆSee details»
Oncos FAQs: answers to frequently asked questions about use.
Oncos FAQ: answers to frequently asked questions about the use of Oncos products and their effectiveness. How to use them and problems they solve.See details»
ONCOS-102 granted US lung cancer orphan drug designation
Jan 12, 2015 Oncos Therapeuticsโ lead compound now has three orphan drug designations in the US and Europe HELSINKI, Finland, January 12, 2015โOncos Therapeutics Ltd., a โฆSee details»
FDA Fast-Tracks Mesothelioma Vaccine Development
Feb 19, 2021 The FDA has fast-tracked development of ONCOS-102, an immunotherapy vaccine, following positive interim results in clinical trials.See details»
OncoLens - Connected, Continuous, Insight-driven โฆ
More than 10% of all cancer centers in the United States count on OncoLens to help improve outcomes through coordinated patient data, in-depth analysis, and actionable clinical decision โฆSee details»
Pathologies and treatment advice - Oncos
Pathologies and treatment advice. The effectiveness of Oncos products to treat skin post cancer therapies. Learn about the results of Oncos products.See details»
Ludwig Cancer Research
Share New York, July 11, 2018 โ Ludwig Cancer Research and the Cancer Research Institute (CRI) announce the initiation of a clinical trial to evaluate the combination of ONCOS-102, an โฆSee details»
Immuno-oncology Firm Advances Lead Asset in Mesothelioma
Jun 16, 2021 He indicated that ONCOS-102 in melanoma and mesothelioma comprises the bulk of H.C. Wainwright's valuation on Targovax but that the immuno-oncology company is also โฆSee details»
Oncos Leaflets - Oncos
Oncos Leaflets. All technical and scientific information on the products of the dermocometical line suitable for Oncos cancer patients.See details»
Community and Advocacy Groups | Oncology Nursing Society
Mar 20, 2025 Cancer Active, Inc., is a nonprofit organization committed to improving the lives of individuals affected by cancer by focusing on wellness, education, and advocacy. Its mission is โฆSee details»